Valhi (VHI) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
6 Aug, 2026Executive summary
Net income attributable to stockholders rose to $22.3M ($0.78/share) in Q2 2026 from $0.9M ($0.03/share) in Q2 2025, driven by higher operating income in all segments, especially Chemicals.
Six-month net income attributable to stockholders increased to $24.3M ($0.85/share) from $17.8M ($0.62/share) year-over-year, reflecting broad-based segment improvements.
Key non-recurring items: $0.21/share from tax increment infrastructure reimbursement and $0.10/share from a gain on building sale in Q2 2026.
Financial highlights
Q2 2026 revenues rose to $627.6M from $571.5M in Q2 2025; six-month revenues increased to $1.19B from $1.11B year-over-year.
Q2 2026 operating income was $67.7M, up from $35.5M in Q2 2025; six-month operating income reached $100.6M, up from $85.6M.
Gross margin improved to 18% in Q2 2026 from 13% in Q2 2025; six-month gross margin stable at 17%.
Cash provided by operating activities was $13.0M for the first six months of 2026, a $147.2M improvement over the prior year.
Income before income taxes was $47.3M in Q2 2026, compared to $15.5M in Q2 2025.
Outlook and guidance
Full-year 2026 consolidated operating income expected to exceed 2025, led by higher Chemicals segment results.
Real Estate Management and Development segment operating income expected to decline as development activities wind down.
Chemicals segment anticipates higher net sales, improved gross and operating margins, and continued benefit from cost reduction initiatives.
Component Products segment expects full-year net sales, gross margin, and operating income margins to surpass 2025 levels.
Management expects continued benefits from cost reduction initiatives and market share gains but notes substantial risks and uncertainties that could impact future results.
Latest events from Valhi
- Net income plunged year-over-year as Chemicals profits fell despite higher sales.VHI
Q1 2026 - Shareholders will vote on director elections and executive compensation at the May 2026 meeting.VHI
Proxy filing - Controlling shareholder support ensures passage of director elections and Say-on-Pay at the 2026 meeting.VHI
Proxy filing - Net loss in 2025 driven by weak Chemicals results, lower TiO2 prices, and higher costs.VHI
Q4 2025 - Dixie Rice's majority stake ensures approval of all board and compensation proposals.VHI
Proxy Filing - Annual meeting to elect seven directors and hold a say-on-pay vote, with online voting available.VHI
Proxy Filing - Q3 2025 net loss of $22.2M driven by Chemicals segment decline and higher tax expense.VHI
Q3 2025 - Net income dropped sharply as Chemicals weakened and interest expense increased.VHI
Q2 2025 - Q3 2024 net income surged to $57.5M on Chemicals strength and LPC acquisition gains.VHI
Q3 2024